Skip to content
  • Our Company
    • Our Purpose
    • Our Leadership
    • Our Locations
  • Our Focus
    • The Problem
    • Uterine Fibroids
    • Endometriosis
    • Prostate Cancer
    • Infertility
  • Our Science
    • Pipeline
    • Relugolix Combination Tablet
    • MVT-602
  • Our Medicines
  • Our Advocacy
    • Forward Together
  • Join The Team
    • Our Culture
    • Our Benefits
    • Open Positions
  • For Media
    • Press Releases
    • Events
    • Presentations
    • Corporate Governance
    • Expanded Access
  • Contact Us
  • Twitter
  • LinkedIn
  • Instagram
  • Pipeline
  • Relugolix Combination Tablet
  • MVT-602
  • Board of Directors
  • Documents & Charters
  • Committee Composition
  • Expanded Access
  • Topic Category: Endometriosis

    3 Ways to Improve Endometriosis Diagnosis

    Getting a diagnosis for endometriosis can take years. Why does this happen?

    Our Company
    • Our Purpose
    • Our Leadership
    • Our Locations
    Our Focus
    • The Problem
    • Uterine Fibroids
    • Endometriosis
    • Prostate Cancer
    • Infertility
    Our Science
    • Pipeline
    • Relugolix Combination Tablet
    • MVT-602
    Our Medicines
    Our Advocacy
    • Forward Together
    Join the Team
    • Our Culture
    • Our Benefits
    • Open Positions
    For Media
    • Press Releases
    • Events
    • Presentations
    • Corporate Governance
    • Expanded Access
    Contact Us

    © 2023 Myovant Sciences GmbH. All rights reserved.

    • Terms of Use
    • Privacy Policy
    • Cookie Policy
    • SMS Terms & Conditions
    • Compliance & Prescriber Information
    OUR COMPANY
    Our Purpose
    Our Leadership
    Our Locations
    OUR FOCUS
    The Problem
    Uterine Fibroids
    Endometriosis
    Prostate Cancer
    Infertility
    OUR SCIENCE
    Pipeline
    Relugolix Combination Tablet
    MVT-602
    OUR MEDICINES
    OUR ADVOCACY
    Forward Together
    JOIN THE TEAM
    Our Culture
    Our Benefits
    Open Positions
    INVESTORS & MEDIA
    Company Overview
    News & Events
    Stock Information
    Financials & Filings
    Corporate Governance
    Email Alerts
    CONTACT US
    TWITTER
    LINKEDIN
    Instagram
    • OUR COMPANY
      • Our Purpose
      • Our Leadership
      • Our Locations
    • OUR FOCUS
      • The Problem
      • Uterine Fibroids
      • Endometriosis
      • Prostate Cancer
      • Infertility
    • OUR SCIENCE
      • Pipeline
      • Relugolix Combination Tablet
      • MVT-602
    • OUR MEDICINES
    • OUR ADVOCACY
      • Forward Together
    • JOIN THE TEAM
      • Our Culture
      • Our Benefits
      • Open Positions
    • INVESTORS & MEDIA
      • Company Overview
      • News & Events
      • Stock Information
      • Financials & Filings
      • Corporate Governance
      • Email Alerts
    • CONTACT US
    • TWITTER
    • LINKEDIN
    • Instagram